Weight Management Research
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreThis is a study of tirzepatide in participants with obesity (overweight). The purpose of this study is to learn more about how tirzepatide maintains body weight or adds to weight loss after an intensive lifestyle modification program.
Participants must have a body mass index (BMI) 30 kg/m² or 27 kg/m²
Participants must be previously diagnosed with at least 1 of the following high blood pressure, high cholesterol, sleep apnea or heart disease
Participants must not have type 1 diabetes or type 2 diabetes
Participant must not have been taking weight loss drugs, including over-the-counter medications during the last 3 months
Participants must not have had a heart attack, stroke, or hospitalization for congestive heart failure in the past 2 months
Participants must not have pancreatitis
Participants must not have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreLearn how Lilly is working with health care partners to improve diversity in our clinical studies.
Watch the VideoA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.